Law360, New York (March 24, 2015, 6:23 PM ET) -- A whistleblower on Monday pressed the First Circuit to revive his False Claims Act suit targeting pharmacy billing by PharMerica Corp., arguing that a lower court wrongly found that an earlier lawsuit was first to spotlight an alleged fraud scheme.
Robert Gadbois, a onetime pharmacist at the long-term-care pharmacy chain, took aim at U.S. District Judge Mary M. Lisi’s conclusion that his complaint about billing for noncontrolled substances had parroted an older lawsuit about billing for controlled substances and therefore had to be tossed under the...
Robert Gadbois, a onetime pharmacist at the long-term-care pharmacy chain, took aim at U.S. District Judge Mary M. Lisi’s conclusion that his complaint about billing for noncontrolled substances had parroted an older lawsuit about billing for controlled substances and therefore had to be tossed under the...
To view the full article, register now.
No comments:
Post a Comment